EM2006E "COVID-19 Coagulopathy: A Distinct Entity?" (IM GR-061920)
The goal of this presentation is to provide a summary of the coagulopathy, thrombotic complications, and anticoagulation management of patients with COVID-19. The presentation will also cover the role of inflammation in thrombosis as well as the vascular endothelial dysfunction associated with COVID-19.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Describe the characteristics of COVID-19 coagulopathy.
- Understand the link between inflammation and thrombosis.
- Describe the clinical consequences of COVID-19 coagulopathy and proposed management strategy.
Ibrahim Ibrahim, M.D.
Assistant Professor, Department of Internal Medicine
Division of Hematology and Oncology
Available Credit
- 1.00 AMA
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome